Schizophrenia
|
0.460 |
Biomarker
|
disease |
BEFREE |
Three of these loci (MTHFR, DAOA, ARVCF) had never been implicated by a schizophrenia GWA study.
|
31455759 |
2019 |
Schizophrenia
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Carriage of the minor allele at rs2518824 in the armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF) gene, which has been linked to neuronal migration and schizophrenia, and rs174576 in the fatty acid desaturase 2 gene, which encodes a rate-limiting enzyme for endogenous long chain polyunsaturated fatty acid synthesis and has been linked to intelligence, was associated with white matter abnormality measured in vivo using diffusion tensor imaging (P = .0009 and P = .0019, respectively).
|
24819575 |
2014 |
Schizophrenia
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
We hypothesized that ARVCF gene haplotypes influence caudate nucleus volume, fractional anisotropy, and neurocognitive functioning in schizophrenia.
|
22053977 |
2012 |
Schizophrenia
|
0.460 |
Biomarker
|
disease |
PSYGENET |
We hypothesized that ARVCF gene haplotypes influence caudate nucleus volume, fractional anisotropy, and neurocognitive functioning in schizophrenia.
|
22053977 |
2012 |
Schizophrenia
|
0.460 |
Biomarker
|
disease |
PSYGENET |
The functional variant rs165815, which affects a critical region of ARVCF, is a considerable source of the genetic variability associated with the risk of developing schizophrenia.
|
20333729 |
2010 |
Schizophrenia
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
The functional variant rs165815, which affects a critical region of ARVCF, is a considerable source of the genetic variability associated with the risk of developing schizophrenia.
|
20333729 |
2010 |
Schizophrenia
|
0.460 |
Biomarker
|
disease |
PSYGENET |
Our results will assist in the interpretation of the controversy generated by genetic associations of COMT and schizophrenia, which could be the result of different LD patterns between COMT markers and the 3' region of the ARVCF gene.
|
19508883 |
2009 |
Schizophrenia
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
The genetic region including the ARVCF gene in the 22q11.21 chromosome is associated with schizophrenia in a Spanish series.
|
19508883 |
2009 |
Schizophrenia
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Either the ARVCF gene itself or a nearby locus may confer susceptibility to schizophrenia in a Chinese Han population.
|
15861775 |
2005 |
Schizophrenia
|
0.460 |
Biomarker
|
disease |
PSYGENET |
Either the ARVCF gene itself or a nearby locus may confer susceptibility to schizophrenia in a Chinese Han population.
|
15861775 |
2005 |
Schizophrenia
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Schizophrenia and related disorders
|
0.310 |
Biomarker
|
group |
PSYGENET |
Three dbSNPs (rs35219372, rs5993890, and rs165815) were identified when the nine exons of ARVCF were resequenced. rs165815 was associated with schizophrenia and related disorders (homozygote CC OR = 3.39, permutated P value = 0.02).
|
20333729 |
2010 |
Schizophrenia and related disorders
|
0.310 |
GeneticVariation
|
group |
BEFREE |
Three dbSNPs (rs35219372, rs5993890, and rs165815) were identified when the nine exons of ARVCF were resequenced. rs165815 was associated with schizophrenia and related disorders (homozygote CC OR = 3.39, permutated P value = 0.02).
|
20333729 |
2010 |
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome-Wide Association Study Identified New Risk Loci for Hirschsprung's Disease.
|
26887379 |
2017 |
DiGeorge Syndrome
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
Shprintzen syndrome
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
Asymmetric crying face association
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
CONOTRUNCAL ANOMALY FACE SYNDROME
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
22q11 Deletion Syndrome
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
22q11 partial monosomy syndrome
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
White Blood Cell Count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Eosinophil count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.
|
30578418 |
2019 |
mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |